Gilead Sciences Inc. (GILD) said it expects earnings for fiscal 2020 to be between $5.15 and $5.55 a share.
On an adjusted basis, the biopharmaceutical company expects full-year earnings in the range of $6.05 to $6.45 a share.
The company also projects product sales to be between $21.8 billion and $22.2 billion for the year.
https://www.marketscreener.com/GILEAD-SCIENCES-4876/news/Gilead-Sciences-Expects-FY20-EPS-of-5-15-to-5-55-29940995/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.